StockData

Rafael Holdings, Inc. (RFL) stock

RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 5/30
$0.92+0.02 (+2.19%)

Close on Nov 20, 2026Market cap $47.99MP/E –Yield –

Rafael gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Rafael's gross profit for the twelve months ending Jan 31, 2025 was $477.00K. For fiscal 2024 it was $483.00K.

Annual gross profit

PeriodPeriod endValueChange
FY2024Jul 31, 2024$483.00K–
FY2022Jul 31, 2022-$3.09M–
FY2021Jul 31, 2021-$2.37M–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2025CQ4 2024Jan 31, 2025$39.00K-45.1%
Q1 FY2025CQ3 2024Oct 31, 2024$91.00K+30.0%
Q4 FY2024CQ2 2024Jul 31, 2024$96.00K–
Q3 FY2024CQ1 2024Apr 30, 2024$251.00K–
Q3 FY2023CQ1 2023Apr 30, 2023$71.00K–
Q2 FY2023CQ4 2022Jan 31, 2023$70.00K–
Q1 FY2023CQ3 2022Oct 31, 2022-$179.00K–
Q4 FY2022CQ2 2022Jul 31, 2022-$760.00K–
Q3 FY2022CQ1 2022Apr 30, 2022-$723.00K–
Q2 FY2022CQ4 2021Jan 31, 2022-$962.00K–
Q1 FY2022CQ3 2021Oct 31, 2021-$644.00K–

More Rafael figures

See a number that looks wrong?